TABLE 2 Treatment outcomes for the linezolid therapy group and the control group
Treatment outcomesLinezolid groupControl groupChi-squaredp-value
Patients n3332
Treatment success23 (69.7)11 (34.4)8.1250.004
 Cure17 (51.5)7 (21.9)6.1280.013
 Treatment completion6 (18.2)4 (12.5)0.4030.526
Poor treatment outcomes10 (30.3)21 (65.6)8.1250.004
 Death2 (6.1)3 (9.4)0.2470.619
 Failure4 (12.1)15 (46.9)9.4860.002
 Default4 (12.1)3 (9.1)0.1260.723
  • Data are presented as n (%) unless otherwise stated.